Drug Shortage Report for HAVRIX 1440
Report ID | 172345 |
Drug Identification Number | 02187078 |
Brand name | HAVRIX - SUS IM 1440 ELISA UNITS/ML |
Common or Proper name | hepatitis A vaccine, inactivated |
Company Name | GLAXOSMITHKLINE INC |
Market Status | MARKETED |
Active Ingredient(s) | HEPATITIS A VACCINE, INACTIVATED |
Strength(s) | 1440UNIT |
Dosage form(s) | SUSPENSION |
Route of administration | INTRAMUSCULAR INTRAMUSCULAR |
Packaging size | 1's (prefilled syringe / seringue préremplie) |
ATC code | J07BC |
ATC description | VIRAL VACCINES |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2022-10-20 |
Estimated end date | 2022-11-30 |
Actual end date | 2022-11-29 |
Shortage status | Resolved |
Updated date | 2022-11-30 |
Company comments | Supply available for public programs. Supply unavailable in the private market. |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2022-11-30 | French | Compare |
v5 | 2022-11-30 | English | Compare |
v4 | 2022-11-23 | French | Compare |
v3 | 2022-11-23 | English | Compare |
v2 | 2022-10-21 | French | Compare |
v1 | 2022-10-21 | English | Compare |
Showing 1 to 6 of 6